Rigel Pharmaceuticals (RIGL) PT Raised to $7 at Piper Jaffray
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $45.89 --0%
Rating Summary:
5 Buy, 8 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 56
Rating Summary:
5 Buy, 8 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 56
Join SI Premium – FREE
Piper Jaffray raised its price target on Rigel Pharmaceuticals (NASDAQ: RIGL) to $7.00 (from $6.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Flowers Foods (FLO) PT Lowered to $6 at Stephens
- Halma Plc. (HLMA:LN) (HLMAF) PT Lowered to GBP49 at Kepler Cheuvreux
- Alkami Technology Inc (ALKT) PT Raised to $25 at Needham
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
